Mustang Bio, Inc. (MBIO) is a publicly traded Healthcare sector company. As of October 15, 2026, MBIO trades at $0.39 with a market cap of $2.80M and a P/E ratio of -1.19. MBIO moved +3.19% today. Year to date, MBIO is -63.92%; over the trailing twelve months it is -76.88%. Its 52-week range spans $0.37 to $7.00. Rallies surfaces MBIO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for MBIO shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $0.39 |
| Market Cap | $2.80M |
| P/E Ratio | -1.19 |
| EPS | $-0.39 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.00 |
| 52-Week Low | $0.37 |
| Volume | 5.72K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-1.92M |
| Gross Margin | 0.00% |
MBIO analyst coverage data. Average price target: $0.00.